Valuation Artivion, Inc. Deutsche Boerse AG
Stocks
CYL
US2289031005
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.70 EUR | -4.62% |
|
-0.85% | -40.08% |
| 06-29 | Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Defensive Index | CI |
| 06-29 | Artivion, Inc.(NYSE:AORT) dropped from Russell Microcap Value Benchmark Index | CI |
Company Valuation: Artivion, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 800.4 | 488.8 | 733.9 | 1,198 | 2,161 | 1,306 | - | - |
| Change | - | -38.93% | 50.16% | 63.29% | 80.29% | -39.57% | - | - |
| Enterprise Value (EV) | 1,058 | 761.4 | 733.9 | 1,198 | 2,161 | 1,306 | 1,306 | 1,306 |
| Change | - | -28.05% | -3.6% | 63.29% | 80.29% | -39.57% | 0% | 0% |
| P/E | -53.6x | -25.3x | -23.8x | -89.3x | 217x | 321x | 66x | 34.1x |
| PBR | 2.7x | 1.72x | - | - | - | - | - | - |
| PEG | - | -1x | -0.4x | 1.6x | -1x | -5.3x | 0x | 0.4x |
| Capitalization / Revenue | 2.68x | 1.56x | 2.07x | 3.08x | 4.9x | 2.69x | 2.42x | 2.17x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.69x | 2.42x | 2.17x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 13.8x | 11.3x | 9.35x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 40.1x | 22.4x | 16.3x |
| EV / FCF | - | - | - | - | - | -67.3x | 67.3x | - |
| FCF Yield | - | - | - | - | - | -1.49% | 1.49% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.38 | -0.48 | -0.75 | -0.32 | 0.21 | 0.0838 | 0.4075 | 0.79 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 298.8 | 313.8 | 354 | 388.5 | 441.3 | 486.2 | 539.8 | 600.8 |
| EBITDA 1 | 44.28 | 41.56 | 53.82 | 71.26 | 89.6 | 94.3 | 115.5 | 139.7 |
| EBIT 1 | 8.117 | 6.201 | 5.742 | 38.87 | 33.74 | 32.57 | 58.29 | 80.33 |
| Net income 1 | -14.83 | -19.19 | -30.69 | -13.36 | 9.768 | 4.4 | 22.59 | 39.24 |
| Net Debt | 257.8 | 272.6 | - | - | - | - | - | - |
| Reference price 2 | 20.35 | 12.12 | 17.88 | 28.59 | 45.61 | 26.90 | 26.90 | 26.90 |
| Nbr of stocks (in thousands) | 39,330 | 40,329 | 41,049 | 41,920 | 47,375 | 48,543 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 24/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.2x | 4.11x | 15.95x | 2.44% | 182B | |
| 19.53x | 3.41x | 11.99x | 3.45% | 110B | |
| 17.04x | 0.19x | 12.04x | 0.77% | 59.59B | |
| 31.84x | 7.93x | 20.18x | 1.25% | 55.04B | |
| 37.04x | 3.28x | 11.19x | 2.31% | 46.87B | |
| 40.3x | 1.45x | 12.76x | 0.2% | 35.55B | |
| 35.05x | 6.15x | 19.32x | -.--% | 32.81B | |
| 40.67x | 7.12x | 25.57x | 0.26% | 24.54B | |
| 25.64x | 3.76x | 13.17x | 1.12% | 22.69B | |
| Average | 30.81x | 4.16x | 15.80x | 1.31% | 63.33B | |
| Weighted average by Cap. | 28.66x | 3.93x | 15.09x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AORT Stock
- CYL Stock
- Valuation Artivion, Inc.
Select your edition
All financial news and data tailored to specific country editions
